APREA THERAPEUTICS INC (APRE) Stock Income Statement
NASDAQ:APRE - Nasdaq - US03836J2015 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.50M | 583.20K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.82M | 16.06M | 113.39M | 37.45M | 52.81M | |||
| Research and Development | 9.36M | 7.63M | 92.42M | 23.90M | 37.88M | |||
| Selling, General, and Administrative Expenses | 6.46M | 8.43M | 20.97M | 13.55M | 14.93M | |||
| Operating Income | -14.32M | -15.47M | -113.39M | -37.45M | -52.81M | |||
| Interest Income/Expense | 1.36M | 1.19M | 730.00K | 320.00K | -670.00K | |||
| Non Recurring Items | N/A | 0.00 | N/A | N/A | N/A | |||
| Income Before Taxes | -12.96M | -14.29M | -112.66M | -37.13M | -53.48M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -12.96M | -14.29M | -112.66M | -37.13M | -53.48M | |||
| EBITDA | -14.30M | -15.46M | N/A | -37.44M | -52.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.35 | -3.95 | -67.86 | -35.02 | -50.45 | |||
| Non GAAP EPS | -2.38 | -3.99 | -30.12 | -26.26 | -2.54 | |||
| Statistics | ||||||||
| Profit Margin | -862.42% | -2449.73% | N/A | N/A | N/A | |||
| Operating Profit Margin | -952.99% | -2652.95% | N/A | N/A | N/A | |||
All data in USD